Chemla Eric S, Korrakuti Lavanya, Makanjuola David, Chang And Rene W
South West London Sector Renal Transplant Unit, St George's Hospital, St Helier Hospital, London, UK.
Ann Vasc Surg. 2005 Sep;19(5):692-8. doi: 10.1007/s10016-005-6624-z.
The purpose of this study was to evaluate the value of complex hemodialysis access procedures among patients with central venous obstruction who were running out of access sites. Between September 2002 and December 2003 we performed a total of 640 new hemodialysis access procedures in 3 renal units. Ten of these patients presented central vein stenosis or obstruction and were not suitable for peritoneal dialysis. Each of the 10 patients had 3 or 4 previous failed access procedures and numerous infected central lines and their dialysis catheters were not functioning adequately. Nine patients presented with a severely stenosed or occluded superior vena cava and 1 had both subclavian veins occluded. Three patients were diabetics, 2 were obese and 6 had hypertension. We performed 12 procedures on these 10 patients. Saphenous veins were used 6 times, twice as a loop to the femoral artery and 4 times as a transposition to the popliteal artery above the knee. Femoral vein transposition to the popliteal artery was carried out in 2 cases. We performed 3 axillary artery to popliteal vein polytetrafluoroethylene (PTFE) bypasses, 1 on an obese woman who had no saphenous vein and was not suitable for a femoral vein transposition, 1 on a diabetic woman whose saphenous vein loop clotted after 5 months and 1 on a female patient with severe peripheral vascular disease. The patient with bilateral subclavian vein occlusion had a brachial artery to internal jugular vein PTFE graft. The PTFE graft to the jugular vein has been patent and regularly needled with a follow-up of 4 months. Four saphenous vein fistulae were regularly used for dialysis; 2 were never used. Five saphenous fistulae clotted after an average life span of 4 months (range 3 weeks-9 months) and 1 is still patent and in use (5 months). Both femoral vein transpositions have been patent and have been needled 3 times a week with a follow-up of 10 and 4 months; one had to be revised surgically after 9 months. Of the 3 axillary artery to popliteal vein grafts, 1 had to be tied off after a week because of severe steal syndrome and 2 have been patent (20 months follow-up) and have been needled regularly ever since. Seventy percent of these patients have been dialyzed line-free through their fistula despite severe central vein stenosis or obstruction for periods of 9-18 months when this review was undertaken. Although the follow-up needs to be longer, we discuss the surgical, radiologic, and dialysis features of these patients and propose a management pathway for central vein stenosis or occlusion.
本研究的目的是评估在中心静脉阻塞且可供建立通路的部位逐渐减少的患者中,复杂血液透析通路建立程序的价值。2002年9月至2003年12月期间,我们在3个肾脏科室共进行了640例新的血液透析通路建立手术。其中10例患者存在中心静脉狭窄或阻塞,不适合进行腹膜透析。这10例患者每人之前都有3或4次通路建立手术失败,且有大量感染的中心静脉导管,其透析导管功能不佳。9例患者表现为上腔静脉严重狭窄或闭塞,1例双侧锁骨下静脉闭塞。3例患者为糖尿病患者,2例肥胖,6例有高血压。我们对这10例患者进行了12次手术。大隐静脉使用了6次,2次作为袢至股动脉,4次作为转位至膝上腘动脉。2例患者进行了股静脉转位至腘动脉手术。我们进行了3例腋动脉至腘静脉的聚四氟乙烯(PTFE)旁路移植术,1例施于一名无大隐静脉且不适合股静脉转位的肥胖女性,1例施于一名糖尿病女性,其大隐静脉袢在5个月后血栓形成,1例施于一名患有严重周围血管疾病的女性患者。双侧锁骨下静脉闭塞的患者进行了肱动脉至颈内静脉的PTFE移植术。至颈静脉的PTFE移植血管通畅,定期进行穿刺,随访4个月。4条大隐静脉内瘘定期用于透析;2条从未使用。5条大隐静脉内瘘在平均4个月(范围3周 - 9个月)的使用寿命后血栓形成,1条仍然通畅并在使用(5个月)。2例股静脉转位均通畅,每周穿刺3次,随访10个月和4个月;其中1例在9个月后进行了手术修正。3例腋动脉至腘静脉移植术中,1例因严重盗血综合征在一周后结扎,2例通畅(随访20个月),此后定期进行穿刺。在进行本次综述时,尽管存在严重的中心静脉狭窄或阻塞,这些患者中有70%通过内瘘无导管透析了9至18个月。尽管随访时间需要更长,但我们讨论了这些患者的手术、放射学和透析特点,并提出了中心静脉狭窄或闭塞的处理方法。